Anticoagulants (Related Reports)

Anticoagulants


October 1, 2012
434 Pages - SKU: GJOB4921030
License type:
PDF E-mail From Publisher      US $4,950.00
Hemophilia B - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Hemophilia B - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hemophilia B - Pipeline Review, H1 2014’, provides an overview of the Hemophilia B’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hemophilia  |  read more...
$2,000.00
Chemotherapy Induced Anemia - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Chemotherapy Induced Anemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2014’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2014
3/19/2014 | published by: GlobalData
Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2014 provides data on the Chemotherapy Induced Anemia clinical trial scenario. This report provides  |  read more...
$2,500.00
Myocardial Infarction - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
Myocardial Infarction - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H1 2014’, provides an overview of the Myocardial Infarction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocardial  |  read more...
$2,000.00
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014’, provides an overview of the Peripheral Arterial  |  read more...
$2,000.00
Chronic Heart Failure - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
Chronic Heart Failure - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chronic Heart Failure - Pipeline Review, H1 2014’, provides an overview of the Chronic Heart Failure’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Myocardial Ischemia - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
Myocardial Ischemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myocardial Ischemia - Pipeline Review, H1 2014’, provides an overview of the Myocardial Ischemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocardial  |  read more...
$2,000.00
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2014
1/31/2014 | published by: Global Markets Direct
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, 'Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2014', provides an overview of the indication’s therapeutic pipeline. This report provides information on  |  read more...
$2,000.00
Myocardial Infarction Partnering 2009-2014
2/1/2014 | published by: Current Partnering
Myocardial Infarction Partnering 2009-2014 The Myocardial Infarction Partnering 2009-2014 provides understanding and access to the myocardial infarction partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of myocardial  |  read more...
$995.00
Hypercholesterolemia Partnering 2009-2014
2/1/2014 | published by: Current Partnering
Hypercholesterolemia Partnering 2009-2014 Hypercholesterolemia Partnering 2009-2014 provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of hypercholesterolemia partnering deals. The majority of  |  read more...
$995.00